癌症。癌症与端粒——端粒酶的替代物 - Suppr

Suppr

超能文献

Cancer. Cancer and telomeres--an ALTernative to telomerase.

作者信息

Shay Jerry W, Reddel Roger R, Wright Woodring E

机构信息

Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

出版信息

Science. 2012 Jun 15;336(6087):1388-90. doi: 10.1126/science.1222394.

DOI:10.1126/science.1222394

PMID:22700908

Abstract

摘要

相似文献

Cancer. Cancer and telomeres--an ALTernative to telomerase.

Science. 2012 Jun 15;336(6087):1388-90. doi: 10.1126/science.1222394.

Telomere maintenance as a target for drug discovery.

J Med Chem. 2014 Feb 13;57(3):521-38. doi: 10.1021/jm400528t. Epub 2013 Oct 15.

Telomeres and telomere dynamics: relevance to cancers of the GI tract.

Expert Rev Gastroenterol Hepatol. 2013 Nov;7(8):733-48. doi: 10.1586/17474124.2013.848790.

Telomere biology of pediatric cancer.

Cancer Invest. 2007 Apr-May;25(3):197-208. doi: 10.1080/07357900701208683.

Targeting telomeres and telomerase.

Biochimie. 2008 Jan;90(1):131-55. doi: 10.1016/j.biochi.2007.07.011. Epub 2007 Jul 24.

Life and cancer without telomerase: ALT and other strategies for making sure ends (don't) meet.

Crit Rev Biochem Mol Biol. 2017 Feb;52(1):57-73. doi: 10.1080/10409238.2016.1260090. Epub 2016 Nov 28.

[Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].

Bull Cancer. 1997 Dec;84(12):1123-33.

Telomeres and telomerase as targets for anticancer drug development.

Crit Rev Oncol Hematol. 2006 Mar;57(3):191-214. doi: 10.1016/j.critrevonc.2005.08.007.

Is telomerase a viable target in cancer?

Mutat Res. 2012 Feb 1;730(1-2):90-7. doi: 10.1016/j.mrfmmm.2011.07.006. Epub 2011 Jul 23.

Agents that target telomerase and telomeres.

Curr Opin Biotechnol. 1996 Dec;7(6):583-91. doi: 10.1016/s0958-1669(96)80068-1.

引用本文的文献

Cellular adaptations impact the biological activity of naphthalene diimide G-quadruplex ligands in ALT-positive osteosarcoma cells.

Cell Death Dis. 2025 Aug 1;16(1):581. doi: 10.1038/s41419-025-07908-2.

Phase Separation in Chromatin Organization and Human Diseases.

Int J Mol Sci. 2025 May 28;26(11):5156. doi: 10.3390/ijms26115156.

Combined inhibition of de novo glutathione and nucleotide biosynthesis is synthetically lethal in glioblastoma.

Cell Rep. 2025 May 27;44(5):115596. doi: 10.1016/j.celrep.2025.115596. Epub 2025 Apr 19.

Telomere Checkpoint in Development and Aging.

Int J Mol Sci. 2023 Nov 5;24(21):15979. doi: 10.3390/ijms242115979.

Alternative Lengthening of Telomeres Is Rare in Canine Histiocytic Sarcoma.

Cancers (Basel). 2023 Aug 22;15(17):4214. doi: 10.3390/cancers15174214.

The Landscape of Telomere Length and Telomerase in Human Embryos at Blastocyst Stage.

Genes (Basel). 2023 May 30;14(6):1200. doi: 10.3390/genes14061200.

TERRA increases at short telomeres in yeast survivors and regulates survivor associated senescence (SAS).

Nucleic Acids Res. 2022 Dec 9;50(22):12829-12843. doi: 10.1093/nar/gkac1125.

Ten Years of CRISPRing Cancers In Vitro.

Cancers (Basel). 2022 Nov 23;14(23):5746. doi: 10.3390/cancers14235746.

ATRX modulates the escape from a telomere crisis.

PLoS Genet. 2022 Nov 9;18(11):e1010485. doi: 10.1371/journal.pgen.1010485. eCollection 2022 Nov.

TERRA and RAD51AP1 promote alternative lengthening of telomeres through an R- to D-loop switch.

Mol Cell. 2022 Nov 3;82(21):3985-4000.e4. doi: 10.1016/j.molcel.2022.09.026. Epub 2022 Oct 19.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Cancer. Cancer and telomeres--an ALTernative to telomerase.

Science. 2012 Jun 15;336(6087):1388-90. doi: 10.1126/science.1222394.

Telomere maintenance as a target for drug discovery.

J Med Chem. 2014 Feb 13;57(3):521-38. doi: 10.1021/jm400528t. Epub 2013 Oct 15.

Telomeres and telomere dynamics: relevance to cancers of the GI tract.

Expert Rev Gastroenterol Hepatol. 2013 Nov;7(8):733-48. doi: 10.1586/17474124.2013.848790.

Telomere biology of pediatric cancer.

Cancer Invest. 2007 Apr-May;25(3):197-208. doi: 10.1080/07357900701208683.

Targeting telomeres and telomerase.

Biochimie. 2008 Jan;90(1):131-55. doi: 10.1016/j.biochi.2007.07.011. Epub 2007 Jul 24.

Life and cancer without telomerase: ALT and other strategies for making sure ends (don't) meet.

Crit Rev Biochem Mol Biol. 2017 Feb;52(1):57-73. doi: 10.1080/10409238.2016.1260090. Epub 2016 Nov 28.

[Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].

Bull Cancer. 1997 Dec;84(12):1123-33.

Telomeres and telomerase as targets for anticancer drug development.

Crit Rev Oncol Hematol. 2006 Mar;57(3):191-214. doi: 10.1016/j.critrevonc.2005.08.007.

Is telomerase a viable target in cancer?

Mutat Res. 2012 Feb 1;730(1-2):90-7. doi: 10.1016/j.mrfmmm.2011.07.006. Epub 2011 Jul 23.

Agents that target telomerase and telomeres.

Curr Opin Biotechnol. 1996 Dec;7(6):583-91. doi: 10.1016/s0958-1669(96)80068-1.

引用本文的文献

Cellular adaptations impact the biological activity of naphthalene diimide G-quadruplex ligands in ALT-positive osteosarcoma cells.

Cell Death Dis. 2025 Aug 1;16(1):581. doi: 10.1038/s41419-025-07908-2.

Phase Separation in Chromatin Organization and Human Diseases.

Int J Mol Sci. 2025 May 28;26(11):5156. doi: 10.3390/ijms26115156.

Combined inhibition of de novo glutathione and nucleotide biosynthesis is synthetically lethal in glioblastoma.

Cell Rep. 2025 May 27;44(5):115596. doi: 10.1016/j.celrep.2025.115596. Epub 2025 Apr 19.

Telomere Checkpoint in Development and Aging.

Int J Mol Sci. 2023 Nov 5;24(21):15979. doi: 10.3390/ijms242115979.

Alternative Lengthening of Telomeres Is Rare in Canine Histiocytic Sarcoma.

Cancers (Basel). 2023 Aug 22;15(17):4214. doi: 10.3390/cancers15174214.

The Landscape of Telomere Length and Telomerase in Human Embryos at Blastocyst Stage.

Genes (Basel). 2023 May 30;14(6):1200. doi: 10.3390/genes14061200.

TERRA increases at short telomeres in yeast survivors and regulates survivor associated senescence (SAS).

Nucleic Acids Res. 2022 Dec 9;50(22):12829-12843. doi: 10.1093/nar/gkac1125.

Ten Years of CRISPRing Cancers In Vitro.

Cancers (Basel). 2022 Nov 23;14(23):5746. doi: 10.3390/cancers14235746.

ATRX modulates the escape from a telomere crisis.

PLoS Genet. 2022 Nov 9;18(11):e1010485. doi: 10.1371/journal.pgen.1010485. eCollection 2022 Nov.

TERRA and RAD51AP1 promote alternative lengthening of telomeres through an R- to D-loop switch.

Mol Cell. 2022 Nov 3;82(21):3985-4000.e4. doi: 10.1016/j.molcel.2022.09.026. Epub 2022 Oct 19.